These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. THOMSON JM; POLLER L Br Med J; 1965 Jul; 2(5456):270-3. PubMed ID: 14310204 [No Abstract] [Full Text] [Related]
4. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
5. OVARIAN FUNCTION DURING AND AFTER LONG-TERM TREATMENT WITH OVULATION INHIBITORS. SHEARMAN RP Lancet; 1964 Sep; 2(7359):557-8. PubMed ID: 14172349 [No Abstract] [Full Text] [Related]
7. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION. JACKSON MC; LINN R Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271 [No Abstract] [Full Text] [Related]
8. ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS. SWYER GI; LITTLE V Br Med J; 1965 May; 1(5447):1412-4. PubMed ID: 14287002 [No Abstract] [Full Text] [Related]
9. THREE CASES OF INTRAVASCULAR THROMBOSIS OCCURRING IN PATIENTS RECEIVING ORAL CONTRACEPTIVES. NEVIN NC; ELMES PC; WEAVER JA Br Med J; 1965 Jun; 1(5450):1586-9. PubMed ID: 14288127 [No Abstract] [Full Text] [Related]
10. CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES. MEARS E Proc R Soc Med; 1964 Mar; 57(3):204-7. PubMed ID: 14130873 [No Abstract] [Full Text] [Related]
11. A FIELD TRIAL WITH LYNDIOL AND CONOVID. SWAAB LI Int J Fertil; 1964; 9():107-10. PubMed ID: 14106240 [No Abstract] [Full Text] [Related]
12. CHOLESTATIC JAUNDICE COMPLICATING PREGNANCY: RECURRENCE AFTER NORETHYNODREL WITH ETHYNYLESTRADIOL (ENOVID). ELLIOTT AJ; HENDRY J Can Med Assoc J; 1965 Feb; 92(7):344-5. PubMed ID: 14243870 [No Abstract] [Full Text] [Related]
14. OVULATION INHIBITION BY PROGESTIN-ESTROGEN COMBINATION. GARCIA CR; PINCUS G Int J Fertil; 1964; 9():95-105. PubMed ID: 14106273 [No Abstract] [Full Text] [Related]
15. DILATION OF THE VEINS WITH PREGNANCY OR WITH ORAL CONTRACEPTIVE THERAPY. WOOD JE; GOODRICH SM Trans Am Clin Climatol Assoc; 1964; 76():174-80. PubMed ID: 14301914 [No Abstract] [Full Text] [Related]
16. EFFECT OF SYNTHETIC ORAL GESTAGENS ON CERVICAL MUCUS AND SPERM PENETRATION. ZANARTU J Int J Fertil; 1964; 9():225-30. PubMed ID: 14106261 [No Abstract] [Full Text] [Related]
17. EIGHT YEARS' EXPERIENCE WITH ORAL CONTRACEPTION AND AN ANALYSIS OF USE OF LOW-DOSAGE NORETHISTERONE. TYLER ET Br Med J; 1964 Oct; 2(5413):843-7. PubMed ID: 14191889 [No Abstract] [Full Text] [Related]
18. EXCRETION OF GONADOTROPINS AND 5-HYDROXYINDOLEACETIC ACID DURING NORMAL AND GESTAGEN-TREATED CYCLES. FUCHS AR; FUCHS F; JOHNSEN SG Int J Fertil; 1964; 9():139-45. PubMed ID: 14106247 [No Abstract] [Full Text] [Related]
19. SMALL-SCALE CLINICAL TRIALS OF PROGESTOGENS FOR CONTROL OF CONCEPTION. SWYER GI Int J Fertil; 1964; 9():11-6. PubMed ID: 14106242 [No Abstract] [Full Text] [Related]